Lubris Bio Pty Ltd: Clinical Trials

2 recruiting, 2 terminated. 4 Phase 2, 2 Phase 1.

By phase and status

Phase	Trials	Status
Phase 2	4	Recruiting 2, Terminated 2
Phase 1	2	Terminated 2

Follow Lubris Bio Pty Ltd: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CROSSOVER STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 μG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE (OGVHD) rhPRG4 450ug/ml, Vehicle Control - Ocular Graft Versus Host Disease	Phase 2	Recruiting	Lubris Bio Pty Ltd	15	2025-09-17	2026-10-26
A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASE Recombinant Human Proteoglycan 4, Vehicle Control - Sjögren's Syndrome	Phase 2	Recruiting	Lubris Bio Pty Ltd	80	2025-09-17	2026-10-28
RHPRG4 FOR THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE (OGVHD) rhPRG4 - Ocular Graft-versus-host Disease	Phase 1 / Phase 2	Terminated	Lubris Bio Pty Ltd	3	2025-02-14	2026-01-21
RHPRG4 FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASE rhPRG4 (450 µg/mL), Vehicle - Sjogren's Syndrome With Dry Eye	Phase 1 / Phase 2	Terminated	Lubris Bio Pty Ltd	8	2024-11-05	2025-09-29

Conditions studied

Dry Eye Syndromes (2)  ·  Graft vs Host Disease (1)  ·  Sjogren's Syndrome (1)

Countries

Australia (4)